Welcome to ATMP Sweden

ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.

Learn about membership

CGT Sweden

Establishing a sustainable national coordination function for Advanced Therapies that strengthens regional centres, supports clinical research, ensures equitable patient access to treatment, and facilitates translation into development and manufacturing.

Learn more

What are ATMPs?

Advanced Therapy Medicinal Products (ATMPs) are a new generation of medicines based on genes, cells, or engineered tissues that can repair, replace, or modify biological functions in the body. These innovative therapies are transforming how diseases can be treated, and sometimes even cured – creating new possibilities for patients with conditions that previously had limited treatment options.

Learn more
DBMD En gemenskap för syskon och anhöriga 2 September 2026 NHTA The Danish Medicines Council launches new company application portal 2 September 2026 NHTA New overview simplifies type 2 diabetes treatment guidance in Denmark 1 September 2026 Testa Center Testa Center Access Grant 2026-2027 18 August 2026 OptiCell Solutions Sweden has a strong opportunity to strengthen its international position in advanced therapy medicinal products (ATMPs) 6 August 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT Q2 2026 – Advancing Clinical Execution 3 July 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT and BBG Advanced Therapies collaborate on P-TEV U.S. readiness 24 June 2026 Testa Center Testa Challenge 2026 Companies Announced 24 June 2026 Alla nyheter Swetrial öppnar utlysningar för att stärka Sveriges kapacitet för kliniska prövningar 1 June 2026 ATMP Flemingsberg Neighbors in collaboration: New partnerships emerge at Novum Labs 29 May 2026 Alla nyheter Ny pusselbit stärker Sveriges position för kliniska prövningar 23 April 2026 QAlliance Course: Advanced GCP in action 8 April 2026 QAlliance Stories from a GCP inspector – part 6 31 March 2026 DBMD När delaktighet skapar livskvalitet: Möt Loa Strandvik 25 March 2026 Vävnadsrådet Viktig information om humanmaterialförordningen 24 March 2026 Magle Biopharma Proud Collaboration Highlight from Path2 Patient Conference 2026 24 March 2026 Magle Biopharma Magle Biopharma had the pleasure of hosting the concluding scientific seminar of the HyperTargIPS-NK project. 11 March 2026 Clinical Trial Consultants We are delighted to welcome two new board members, Pernilla Sandwall and Marie Gårdmark, to Clinical Trial Consultants 6 March 2026 Vävnadsrådet Bröstmjölk och tarmflora: Informationsmöte 11 February 2026 OptiCell Solutions OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration 5 February 2026 Swelife Nationell samordningsfunktion kring ATMP 4 February 2026 PHI Phase Holographic Imaging PHI AB Announces Intent to File for Bankruptcy 12 January 2026 PHI Interim Report 2 2025/26 19 December 2025 ATMP Flemingsberg 50 years of life-changing therapies 16 December 2025 Swelife EHDS börjar med indata 9 October 2025 Clinical Trial Consultants Meet our people pt. 9 – Dr. Ulrika Risedal, MD, Resident in Clinical Pharmacology 26 September 2025 ASCRO Vägledning 2.0 – viktiga framgångsfaktorer när kliniska läkemdelsprövningar initieras och genomförs i Sverige 10 September 2025 NMS New Modalities Nordic Investor Forum in September attracts top investors, academia and industry leaders – ”Interest is high – and rightly so” 12 June 2025 ASCRO Vägledning för kliniska prövningar nu tillgänglig på engelska 3 February 2025 IndiCell Alice Hägg, klarade halvtidsrecension med beröm 25 September 2024 IndiCell Jana Bonsberger, utför sin halvrecension på ett exceptionellt sätt 20 September 2024 DBMD En gemenskap för syskon och anhöriga 2 September 2026 NHTA The Danish Medicines Council launches new company application portal 2 September 2026 NHTA New overview simplifies type 2 diabetes treatment guidance in Denmark 1 September 2026 Testa Center Testa Center Access Grant 2026-2027 18 August 2026 OptiCell Solutions Sweden has a strong opportunity to strengthen its international position in advanced therapy medicinal products (ATMPs) 6 August 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT Q2 2026 – Advancing Clinical Execution 3 July 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT and BBG Advanced Therapies collaborate on P-TEV U.S. readiness 24 June 2026 Testa Center Testa Challenge 2026 Companies Announced 24 June 2026 Alla nyheter Swetrial öppnar utlysningar för att stärka Sveriges kapacitet för kliniska prövningar 1 June 2026 ATMP Flemingsberg Neighbors in collaboration: New partnerships emerge at Novum Labs 29 May 2026 Alla nyheter Ny pusselbit stärker Sveriges position för kliniska prövningar 23 April 2026 QAlliance Course: Advanced GCP in action 8 April 2026 QAlliance Stories from a GCP inspector – part 6 31 March 2026 DBMD När delaktighet skapar livskvalitet: Möt Loa Strandvik 25 March 2026 Vävnadsrådet Viktig information om humanmaterialförordningen 24 March 2026 Magle Biopharma Proud Collaboration Highlight from Path2 Patient Conference 2026 24 March 2026 Magle Biopharma Magle Biopharma had the pleasure of hosting the concluding scientific seminar of the HyperTargIPS-NK project. 11 March 2026 Clinical Trial Consultants We are delighted to welcome two new board members, Pernilla Sandwall and Marie Gårdmark, to Clinical Trial Consultants 6 March 2026 Vävnadsrådet Bröstmjölk och tarmflora: Informationsmöte 11 February 2026 OptiCell Solutions OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration 5 February 2026 Swelife Nationell samordningsfunktion kring ATMP 4 February 2026 PHI Phase Holographic Imaging PHI AB Announces Intent to File for Bankruptcy 12 January 2026 PHI Interim Report 2 2025/26 19 December 2025 ATMP Flemingsberg 50 years of life-changing therapies 16 December 2025 Swelife EHDS börjar med indata 9 October 2025 Clinical Trial Consultants Meet our people pt. 9 – Dr. Ulrika Risedal, MD, Resident in Clinical Pharmacology 26 September 2025 ASCRO Vägledning 2.0 – viktiga framgångsfaktorer när kliniska läkemdelsprövningar initieras och genomförs i Sverige 10 September 2025 NMS New Modalities Nordic Investor Forum in September attracts top investors, academia and industry leaders – ”Interest is high – and rightly so” 12 June 2025 ASCRO Vägledning för kliniska prövningar nu tillgänglig på engelska 3 February 2025 IndiCell Alice Hägg, klarade halvtidsrecension med beröm 25 September 2024 IndiCell Jana Bonsberger, utför sin halvrecension på ett exceptionellt sätt 20 September 2024
ATMP Sweden 2026

ATMP Sweden 2026

The premiere national meetup for the Swedish ATMP ecosystem is coming to Campus Flemingsberg in Stockholm, December 2026.

Read more
Poster Session

Poster Session

ATMP Sweden 2026 will host a poster / abstract zone. Submissions go through a review process – applicants who have their submission chosen will be notified via email. Deadline 16th October 2026.

Submission Form
ATMP Sweden Webinars

ATMP Sweden Webinars

Join to learn from experts, patient advocates, and rising stars within ATMPs:

Read more

Events

7 September 2026 – 9 September 2026 Conference & Congress

Advanced Therapies Europe 2026

Six hundred senior cell and gene therapy leaders gather in Barcelona this September for three days of partnering, investment talk and debate on how Europe turns advanced therapy science into approved treatments.

Auditorium 2, Rigshospitalet Clinical Academic Group for Advanced Therapy Medicinal Products (CAG-ATMP), Greater Copenhagen Health Science Partners (GCHSP)

Gene and Cell Therapies in Danish Healthcare Systems

10 September 2026 Webinar / Digital Event

ATMP Lunch Webinar: Understanding ATMP Approval

Online Lif – The Danish Association of the Pharmaceutical Industry

Lif hosts an online lunch webinar on how advanced therapy medicinal products are approved, with speakers from the Danish Medicines Agency and Novartis. Free to attend and held in English.

14 September 2026 – 16 September 2026 Conference & Congress

Nordic Conference on Future Health 2026

Clarion Hotel Copenhagen Airport Nordic Society of Human Genetics and Precision Medicine (NSHG-PM), Statens Serum Institut (SSI), Nordic Biobank Network

The Nordic Conference on Future Health 2026 brings together researchers, clinicians and decision-makers in Copenhagen to explore how Nordic biobanks and health data can advance precision medicine responsibly.

News

Testa Center access grant part-funds bioprocess scale-up weeks

Bioprocess development at Testa Center in Uppsala is now part-funded again: up to five weeks of access per project, with 70 percent of the access fee covered for academic projects and 50 percent for companies. Weeks are allocated first come, first served and must be used by 30 April 2027.

Sahlgrenska to establish pre-GMP laboratory for ATMP developers
Sahlgrenska Universitetssjukhuset Sahlgrenska Universitetssjukhuset Original source

A pre-GMP laboratory in Western Sweden will let ATMP developers prove out their manufacturing processes before committing to a GMP facility. It is one of two resources in Precisionsplattformen, backed by SEK 25 million in EU regional development and Västra Götalandsregionen funding.

IVA ATMP report: what Sweden must fix to stay competitive
Royal Swedish Academy of Engineering Sciences (IVA) Original source

The Royal Swedish Academy of Engineering Sciences has set out what Sweden needs to change to hold its position in advanced therapies. The IVA ATMP report asks for three national super-ecosystems, a transferable fast-track voucher at EU level and clearer national guidance on the hospital exemption.

2026-04-23 Jobs, Careers & Opportunities

Join the ESGCT ECR Board – Apply by 15 May 2026

Join the ESGCT ECR Board – Apply by 15 May 2026

The European Society of Gene and Cell Therapy is looking for its next ECR Board Member. Are you a PhD student or post-doc in gene and cell therapy? Applications close 15 May 2026.

Doctoral Course: From Research to ATMP Treatment
Flemingsberg Science Foundation natasha.bank@flemingsbergscience.se

Doctoral Course: From Research to ATMP Treatment

BioLamina secures €20M to scale cell therapy tech

EIB backs Swedish biotech scale-up BioLamina with €20 million to enable stem cell technologies targeting diseases such as type 1 diabetes, Parkinson’s disease, and heart failure

Commercial Aspects of ATMPs
Commercial aspects of ATMPs

Learn more about the Health Technology Assessment related issues of your ATMP development.

ATMP Process Map
ATMP Process Map

Support in navigating ATMP development needs prompting the right competence, need, and time.

Job Board
Job Board

Find or advertise ATMP relevant job opportunities.

Newsletter
Newsletter

The ATMP Sweden newsletter provides updates on Swedish ATMP- and association developments.